TG Therapeutics's total assets for Q4 2024 were $577.69M, a decrease of -1.42% from the previous quarter. TGTX total liabilities were $355.33M for the fiscal quarter, a -9.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.